86-4595-76 Recombinant Human Novel Coronavirus Spike glycoprotein(S),partial,Biotinylated (Active) 1mg CSB-MP3324GMY1-B
[WUHAN HUAMEI BIOTECH Co.,Ltd(CUSABIO)]仕様
- Uniprot ID:P0DTC2
- Research Topic:Others
- Gene Names:S
- Organism:Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
- Source:Mammalian cell
- Expression Region:319-541aa
- Sequence Info:Partial
- Tag Info:C-terminal mFc-Avi-tagged
- AA Sequence:RVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNF
- MW:54.1 kDa
- Alternative Name(s):/
- Purity:Greater than 85% as determined by SDS-PAGE.
- Biological_Activity:Measured by its binding ability in a functional ELISA. Immobilized human ACE2 at 2 μg/ml can bind Biotinylated-SARS-CoV-2-S1-RBD (CSB-MP3324GMY1-B), the EC50 is 5.087-7.050 ng/ml.
- Activity Image Link:https://www.cusabio.com/uploadfile/protein/1/CSB-MP3324GMY1-B-AC1.jpg
- Storage Buffer:Lyophilized from a 0.2 μm filtered 20 mM Tris-HCl, 0.5 M NaCl, 6% Trehalose, pH 8.0
- Image Description:(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
- Endotoxin:Less than 1.0 EU/ug as determined by LAL method.
- Form:Lyophilized powder
- Reconstitution:We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
- サイズ:1mg
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





